Allurion Announces New U.S. Patents for Next-Gen Weight Loss Device
Allurion Announces New U.S. Patents for Next-Gen Weight Loss Device Allurion Technologies, Inc. (NYSE: ALUR), a company focused on ending obesity, announced today that it has received two Issue Notifications from the U.S. Patent and Trademark Office (USPTO) for its…
GeneDx Expands Exome and Genome Testing to Include Cerebral Palsy
GeneDx Expands Exome and Genome Testing to Include Cerebral Palsy GeneDx (Nasdaq: WGS), a leader in providing genomic insights to enhance health outcomes, announced today the expansion of its genetic testing services to include cerebral palsy (CP). In celebration of…
GE HealthCare Unveils Genesis Portfolio to Accelerate Digital Innovation Adoption
GE HealthCare Unveils Genesis Portfolio to Accelerate Digital Innovation Adoption GE HealthCare (Nasdaq: GEHC) has announced the launch of its new Genesis solutions, a comprehensive portfolio of cloud-based enterprise imaging software-as-a-service (SaaS) offerings. When commercially released, Genesis will feature four…
Cadrenal Therapeutics Partners with Abbott for Tecarfarin Pivotal Study in HeartMate 3™ LVAD Patients
Cadrenal Therapeutics Partners with Abbott for Tecarfarin Pivotal Study in HeartMate 3™ LVAD Patients Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company specializing in cardiovascular therapeutics, has announced the signing of a Collaboration Agreement with Abbott (NYSE: ABT). This partnership…
Sensus Healthcare Study Shows SRT-100® Prevents Keloid Recurrence at Taiwan’s Tri-Service Military Hospital
Sensus Healthcare Study Shows SRT-100® Prevents Keloid Recurrence at Taiwan’s Tri-Service Military Hospital Sensus Healthcare, Inc. (Nasdaq: SRTS), a leading medical device company focused on providing effective, non-invasive, and cost-efficient treatments for both oncological and non-oncological skin conditions, has announced…
InductiveHealth Partners with Origami Risk to Modernize Public Health Surveillance
InductiveHealth Partners with Origami Risk to Modernize Public Health Surveillance InductiveHealth, a leading provider of disease and syndromic surveillance systems and services, has announced an exclusive partnership with Origami Risk, a global leader in risk, safety, and insurance Software as…
Epredia Gets FDA 510(K) Clearance for E1000 Dx™ Digital Pathology Solution
Epredia Gets FDA 510(K) Clearance for E1000 Dx™ Digital Pathology Solution Epredia, a global leader in precision cancer diagnostics and a subsidiary of PHC Holdings Corporation, announced today that it has received U.S. Food and Drug Administration (FDA) 510(K) clearance…
Ntracts Acquires Compliatric to Enhance Healthcare Compliance Support
Ntracts Acquires Compliatric to Enhance Healthcare Compliance Support Ntracts, a leader in contract lifecycle management (CLM) solutions for the healthcare industry, announced today the acquisition of Compliatric, a provider of regulatory, accreditation, and compliance management technology for healthcare organizations. This…
FDA Grants Orphan and Pediatric Designations to NEU-001 for Hirschsprung’s Disease
FDA Grants Orphan and Pediatric Designations to NEU-001 for Hirschsprung’s Disease Neurenati Therapeutics Inc., a biotechnology company dedicated to pediatric rare diseases, is excited to announce that the U.S. Food and Drug Administration (FDA) has granted both Orphan Drug and…
TEVIMBRA Approved in U.S. for Advanced Esophageal Cancer with Chemotherapy
TEVIMBRA Approved in U.S. for Advanced Esophageal Cancer with Chemotherapy BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company set to change its name to BeOne Medicines Ltd., today announced that the U.S. Food and Drug Administration…
Centauri Therapeutics Selects First Clinical Candidate for Gram-Negative Infection Treatment
Centauri Therapeutics Selects First Clinical Candidate for Gram-Negative Infection Treatment Centauri Therapeutics Limited, an immunotherapy company leveraging its unique Alphamer® platform technology, has announced the selection of its first clinical candidate in the ABX-01 program. This groundbreaking compound is designed…
Sofinnova Partners Raises €1.2 Billion to Drive Life Sciences Innovation
Sofinnova Partners Raises €1.2 Billion to Drive Life Sciences Innovation Sofinnova Partners, a leading European venture capital firm specializing in life sciences, has announced the successful raising of €1.2 billion over the past year across its diverse investment strategies. This…